Ventyx Biosciences, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Ventyx Biosciences details its 2024 financial results and provides updates on its clinical-stage pipeline of oral therapies for autoimmune, inflammatory, and neurodegenerative diseases.
Ventyx Biosciences, a clinical-stage biopharmaceutical company, released its full year 2023 results, highlighting progress in its clinical programs and strategic focus on immunology.